Intravenous Therapy and Vein Access Devices Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032
The Intravenous Therapy and Vein Access Devices Market Size accounted for USD 25.2 Billion in 2022 and is estimated to achieve a market size of USD 44.1 Billion by 2032 growing at a CAGR of 5.8% from 2024 to 2032.
Intravenous (IV) Therapy and Vein Access Devices Market Highlights
- Global intravenous therapy and vein access devices market revenue is poised to garner USD 44.1 billion by 2032 with a CAGR of 5.8% from 2024 to 2032
- North America intravenous therapy and vein access devices market value occupied around USD 8.8 billion in 2022
- Asia-Pacific intravenous therapy and vein access devices market growth will record a CAGR of more than 6.4% from 2024 to 2032
- Among application, the medication administration sub-segment generated more than USD 11.8 billion revenue in 2022
- Based on product type, the intravenous catheter sub-segment generated around 55% market share in 2022
- Rising demand for minimally invasive treatments and personalized medicine is a popular intravenous therapy and vein access devices market trend that fuels the industry demand
Intravenous (IV) therapy involves the infusion of liquid substances such as electrolytes, medicines, nutrition, and blood-based products directly into the veins as a therapeutic treatment. IV therapy is the fastest way to deliver fluids to various parts of the body. In emergencies such as heart attack, stroke, and poisoning, patients need immediate medication, making IV therapy essential. Some medications prescribed intravenously include chemotherapy drugs, antibiotics, antifungal drugs, pain medications, immunoglobulin medication, drugs for low blood pressure, and others. IV therapy works quickly, is easy to monitor, and helps avoid gastrointestinal side effects. It provides a faster immune system response and quicker relief from chronic diseases compared to oral medication. IV therapy can be easily monitored, and the use of infusion pumps helps control the volume of substances administered into the body.
Global Intravenous Therapy and Vein Access Devices Market Dynamics
Market Drivers
- Increasing demand for advanced medical treatments and procedures
- Growth in chronic diseases such as cancer and diabetes
- Rising aging population requiring frequent medical interventions
- Technological advancements in IV therapy devices and equipment
Market Restraints
- Risk of infection associated with intravenous therapy procedures
- High cost of advanced IV therapy devices and treatments
- Regulatory challenges and complex approval processes
Market Opportunities
- Expansion of telemedicine and remote monitoring for IV therapy
- Increasing adoption of home-based IV therapy for chronic patients
- Development of smart IV devices with improved safety and monitoring features
Intravenous (IV) Therapy and Vein Access Devices Market Report Coverage
| Market | Intravenous Therapy and Vein Access Devices Market |
| Intravenous Therapy and Vein Access Devices Market Size 2022 | USD 25.2 Billion |
| Intravenous Therapy and Vein Access Devices Market Forecast 2032 |
USD 44.1 Billion |
| Intravenous Therapy and Vein Access Devices Market CAGR During 2024 - 2032 | 5.8% |
| Intravenous Therapy and Vein Access Devices Market Analysis Period | 2020 - 2032 |
| Intravenous Therapy and Vein Access Devices Market Base Year |
2022 |
| Intravenous Therapy and Vein Access Devices Market Forecast Data | 2024 - 2032 |
| Segments Covered | By Product Type, By Application, By End-User, And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | Tekni-Plex, Fresenius Kabi, Iradimed Corporation, Teleflex Incorporated, Polymedicure, Medtronic plc, Vygon SAS, Smiths Medical, Inc., Baxter International, Terumo Medical Corporation, Becton, Dickinson and Company, and ICU Medical, Inc. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Intravenous Therapy and Vein Access Devices Market Insights
The market for intravenous treatment and vein access devices is expanding due to a variety of causes, most notably the increasing occurrence of trauma cases and road traffic accidents. As more individuals sustain injuries that need prompt medical treatment, the demand for IV therapy as a quick, effective way to give fluids, medicines, and blood products straight into the veins grows. This type of therapy is critical in emergency situations, because prompt treatment can save lives. The expanding senior population is another key driver of the IV treatment industry. Older people sometimes require more regular medical care and treatment for chronic illnesses including diabetes, heart disease, and cancer. Intravenous therapy is an important component of their treatment plan, offering a speedy and effective means to provide medicine and nutrition.
However, the market faces hurdles. There is a possibility of allergic responses with IV therapy, which can complicate treatment and result in negative consequences. Furthermore, IV treatment requires qualified specialists to administer properly, and the market is constrained by a lack of appropriately trained workers. Strict government policies and restrictions can also impede the adoption of new technology and equipment. Despite these limitations, there are potential for development. The increasing healthcare infrastructure in emerging nations is a significant source of opportunity. These areas are seeing a surge in demand for advanced medical treatments and facilities, creating an ideal environment for the expansion of IV therapy and vein access devices. As these markets grow, there will be more opportunities for businesses to provide new goods and services that meet local demands.
Another potential derives from the shift towards home healthcare, which might be especially useful for IV treatment. As more patients seek therapy in the comfort of their own homes, there is an increasing demand for portable and user-friendly IV devices that allow for easy administration. Furthermore, technological advancements are making it possible to develop smarter, more effective IV treatment equipment. These developments have the potential to improve patient outcomes, increase safety, and shorten the administration procedure, all of which will contribute to market growth.
Intravenous Therapy and Vein Access Devices Market Segmentation
The worldwide market for intravenous therapy and vein access devices is split based on product type, application end-user, and geography.
Intravenous (IV) Therapy and Vein Access Devices Market By Product Type
- Implantable Port
- Single Lumen Implantable Port
- Double Lumen Implantable Port
- Intravenous Catheter
- Peripheral Intravenous Catheter
- Central Intravenous Catheter
- Peripherally Inserted Central Catheter
- Hypodermic Needles
- Infusion Pumps
- Other Products
According to intravenous therapy and vein access devices industry analysis, the intravenous catheter segment is the largest due to its broad use in a variety of medical settings. Intravenous catheters carry drugs, fluids, and blood products straight into a patient's bloodstream. This makes them important in a variety of medical settings, including hospitals, clinics, and even home healthcare facilities. Intravenous catheters are classified as peripheral, central, or peripherally implanted central catheters, with each providing a unique purpose based on the patient's medical needs. These catheters are versatile enough to be utilized in a variety of therapies, including chemotherapy, pain management, and feeding and hydration. Their ease of use and ability to provide instant access to a patient's bloodstream have helped the sector dominate the market.
Intravenous (IV) Therapy and Vein Access Devices Market By Application
- Volume Expanders
- Medication Administration
- Blood Based Products
- Nutrition and Buffer Solution
The Medication Administration segment dominates the intravenous (IV) therapy and vein access devices market due to its crucial role in delivering essential pharmaceuticals directly into the circulation. This approach enables quick and effective absorption, which is critical in emergency circumstances like heart attacks, strokes, or trauma where time is of the importance. Intravenous medicine is often necessary for addressing chronic illnesses such as cancer, autoimmune disorders, and serious infections. Because IV administration bypasses the digestive system, it allows more control over dose and timing, allowing for precise and quick therapeutic effects, which has contributed to its commercial domination.
Intravenous (IV) Therapy and Vein Access Devices Market By End-User
- Hospitals
- Ambulatory Surgical Centers
- Clinics
Several reasons contribute to the Hospitals segment's lead in the market and expected to grow over the intravenous therapy and vein access devices industry forecast period. Hospitals are the principal providers of acute and critical care, with intravenous therapy being widely used for a variety of medical operations, surgeries, and treatments. Their huge patient population and wide variety of medical specializations create a significant need for intravenous treatment and vein access devices. Furthermore, hospitals often have more modern infrastructure, technology, and competent healthcare staff, allowing them to efficiently manage complex situations needing IV treatment. As a result, the Hospitals sector is prominent in the market.
Intravenous Therapy and Vein Access Devices Market Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Intravenous Therapy and Vein Access Devices Market Regional Analysis
In terms of intravenous therapy and vein access devices market analysis, North America dominates the industry, owing to a number of factors. The region's strong healthcare infrastructure and widespread use of medical technology contribute considerably to its leadership position. In North America, the prevalence of chronic illnesses such as diabetes, cancer, and heart disease need regular intravenous treatment. Furthermore, increased healthcare expenditure and significant investment in R&D by key industry players drive market expansion.
Asia-Pacific is the market's fastest-growing region and it will grow throughout the intravenous therapy and vein access devices market forecast period, owing to rising population, higher healthcare expenditure, and an expanding middle class with better access to healthcare services. The region's rising burden of chronic illnesses, such as cancer and diabetes, along with a surge in medical tourism, is boosting demand for modern medical treatments, including intravenous therapy. Furthermore, supporting government efforts and a focus on upgrading healthcare infrastructure help to fuel Asia-Pacific's rapid market expansion. As a result, this region is becoming increasingly important for firms in the intravenous (IV) treatment and vein access device market.
Intravenous (IV) Therapy and Vein Access Devices Market Players
Some of the top intravenous therapy and vein access devices companies offered in our report includes Tekni-Plex, Fresenius Kabi, Iradimed Corporation, Teleflex Incorporated, Polymedicure, Medtronic plc, Vygon SAS, Smiths Medical, Inc., Baxter International, Terumo Medical Corporation, Becton, Dickinson and Company, and ICU Medical, Inc.
Frequently Asked Questions
How big is the intravenous therapy and vein access devices market?
The intravenous therapy and vein access devices market size was valued at USD 25.2 Billion in 2022.
What is the CAGR of the global intravenous therapy and vein access devices market from 2024 to 2032?
The CAGR of intravenous therapy and vein access devices is 5.8% during the analysis period of 2024 to 2032.
Which are the key players in the intravenous therapy and vein access devices market?
The key players operating in the global market are including Tekni-Plex, Fresenius Kabi, Iradimed Corporation, Teleflex Incorporated, Polymedicure, Medtronic plc, Vygon SAS, Smiths Medical, Inc., Baxter International, Terumo Medical Corporation, Becton, Dickinson and Company, and ICU Medical, Inc.
Which region dominated the global intravenous therapy and vein access devices market share?
North America held the dominating position in intravenous therapy and vein access devices industry during the analysis period of 2024 to 2032.
Which region registered fastest CAGR from 2024 to 2032?
Europe region exhibited fastest growing CAGR for market of intravenous therapy and vein access devices during the analysis period of 2024 to 2032.
What are the current trends and dynamics in the global intravenous therapy and vein access devices industry?
The current trends and dynamics in the intravenous therapy and vein access devices industry include increasing demand for advanced medical treatments and procedures, growth in chronic diseases such as cancer and diabetes, rising aging population requiring frequent medical interventions, and technological advancements in IV therapy devices and equipment.
Which application held the maximum share in 2022?
The medication administration application held the maximum share of the intravenous therapy and vein access devices industry.?
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
